Linagliptin plus metformin combination was as effective at lowering hemoglobin A1c as glimepiride plus metformin, and with weight loss and less hypoglycemia SAN DIEGO, June 24, 2011 /PRNewswire/ -- ...

INGELHEIM, Germany & INDIANAPOLIS--(BUSINESS WIRE)--EX US, UK and UAE Medical Media Only. Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced results of a 24-week open label arm ...

"I think these are very interesting findings, even if the study wasn't powered for cardiovascular end points," said lead investigator Dr Baptist Gallwitz (Eberhard-Karls-University Tübingen, Germany).

If you need a drug for Type 2 diabetes, Consumer Reports has long advised that a time-tested older medication called metformin is your safest and best first bet. Two studies published Monday, both ...

Linagliptin is the only diabetes treatment to be approved once daily, one dosage strength for all adult patients without any need for dose adjustments Ingelheim, Germany 25.08.2011- Boehringer ...

The fixed combination of the drugs saxagliptin and metformin (Komboglyze®) has been approved in Germany since November 2011 for the treatment of type 2 diabetes mellitus. In an early benefit ...

(HealthDay)—Linagliptin is noninferior to glimepiride for adults with relatively early type 2 diabetes and elevated cardiovascular risk, according to a study published online Sept. 19 in the Journal ...

Type 2 Diabetes: Jardiance® (empagliflozin) as an add-on therapy significantly reduced blood glucose and body weight in two newly presented Phase III trials Added to metformin, empagliflozin ...

The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of 42 new drugs as per the provisions of the Drugs Prices Control Order (DPCO), 2013, including several anti-diabetes, ...